Stable ophthalmic composition used for dilating the pupil for diagnostic or therapeutic procedures, comprises phenylephrine or its salt, and excipients
2023-07-12
专利权人MANKIND PHARMA LTD (MANK-Non-standard)
申请日期2023-07-12
专利号IN202311033580-A
成果简介NOVELTY - Stable ophthalmic composition comprises: phenylephrine or its salt, and excipients, where composition is an aqueous solution having a pH of 5.0-6.5. USE - Stable ophthalmic composition used for dilating the pupil for diagnostic or therapeutic procedures. ADVANTAGE - The composition exhibits ease of manufacture, ease of administration, and acheive specific bioavailability and stability. DETAILED DESCRIPTION - An INDEPENDENT CLAIM is included for a process for preparing a stable ophthalmic composition, which involves: (a) adding and mixing buffers in water to get a clear solution; (b) adding phenylephrine or its salt, to the above solution under stirring to obtain a clear solution; (c) optionally adding benzalkonium chloride to above solution; (d) adding pH adjusting agents selected from sodium hydroxide, hydrochloric acid, phosphoric acid, or combinations, to adjust the initial pH of the composition in the range of 5.5-6.0; (e) making up the volume of the solution to 100% with water; and (f) filtering the solution and filling aseptically in vial.
IPC 分类号A61K-031/137
国家印度
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/21323
专题中国科学院新疆生态与地理研究所
作者单位
MANKIND PHARMA LTD (MANK-Non-standard)
推荐引用方式
GB/T 7714
KUMAR A,UPADHYAY S C,HASIJA R,et al. Stable ophthalmic composition used for dilating the pupil for diagnostic or therapeutic procedures, comprises phenylephrine or its salt, and excipients. IN202311033580-A[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。